Return On Equity ratio Analysis of Immuneering Corp - Deep Dive


Latest FY ROE
Period Ending - Dec-23

-0.057


Very Poor ROE
Period Ending - Dec-22
-45.98

Very Poor ROE
Growth
99.88 %
Trailing Twelve Months ROE
Period Ending - Dec-23

-64.50


Very Poor ROE
Most recent Quarter ROE
Period Ending - Mar-24

-18.17


Very Poor ROE
ROE Analysis of Immuneering Corp
ROE Ratio of Immuneering Corp with value of -64.50 means is not able to effectively utilize its Shareholders Fund in order to generate a profit in trailing twelve months.
ROE Ratio of Immuneering Corp with value of -18.17 means is not able to effectively utilize its Shareholders Fund in order to generate a profit in latest Quarter ending on Mar-24.
ROE Ratio of IMRX rose handsomely by 99.88 % this year.
ROE Ratio with value of 0 was highest in Year Dec-20 in last Five Years.
ROE Ratio with value of -45.98 was lowest in Year Dec-22 in last Five Years.
Latest ROE Ratio with value of -0.057 is Greater than Average ROE of -13.51 in last five years.
ROE of Immuneering Corp is negative because of poor net profit in last Financial Year , last Quarter and also in last twelve Months.
Other ROE Related Info of IMRX that may interest you.
Immuneering Corp Overview
CodePricePrevious PricePrice ChangeSector
IMRX1.471.54 4.55 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of Return On Equity
The Return on Equity (ROE) is a profitability metric that measures a company's ability to generate profits using its shareholder's fund. ROE is calculated by dividing Net Income by Shareholders' Fund.   more ..
Return On Equity Formula
ROE Related Ratios
ReturnOnAssetNetProfitMargin
Tsr Profitability Index
Poor Profitability Stock
FY - Historical Return On Equity of Immuneering Corp
PeriodDec-23Dec-22Dec-21Dec-20Dec-19
ROE-0.057-45.98-21.5000
Change99.88 %-113.88 %
FY Chart of Return On Equity of Immuneering Corp


Note : All Data Generated at the End of Trading Hours (EOD Data)